Axa’s AMAG Pharmaceuticals AMAG Stock Holding History

Axa’s Portfolio AMAG Stock Details AMAG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-188,200	Closed	-$1.77M	–	1390
2020 Q3	$1.77M	Hold	188,200	–	–	0.01%	838
2020 Q2	$1.44M	Sell	188,200 -7,700	-4%	-$58.9K	0.01%	882
2020 Q1	$1.21M	Buy	195,900 +63,200	+48%	+$557K	0.01%	824
2019 Q4	$1.61M	Hold	132,700	–	–	0.01%	834
2019 Q3	$1.53M	Sell	132,700 -1,800	-1%	-$18.9K	0.01%	913
2019 Q2	$1.34M	Sell	134,500 -11,200	-8%	-$121K	0.01%	918
2019 Q1	$1.88M	Buy	145,700 +58,300	+67%	+$868K	0.01%	864
2018 Q4	$1.33M	Sell	87,400 -6,200	-7%	-$118K	0.01%	911
2018 Q3	$1.87M	Buy	93,600 +64,100	+217%	+$1.46M	0.01%	892
2018 Q2	$575K	Buy	+29,500	New	+$653K	﹤0.01%	1110
2016 Q1	–	Sell	-82,200	Closed	-$2.48M	–	1458
2015 Q4	$2.48M	Buy	82,200 +4,600	+6%	+$149K	0.01%	734
2015 Q3	$3.08M	Buy	77,600 +25,600	+49%	+$1.59M	0.01%	687
2015 Q2	$3.59M	Buy	52,000 +6,600	+15%	+$415K	0.01%	656
2015 Q1	$2.48M	Sell	45,400 -1,500	-3%	-$71.5K	0.01%	757
2014 Q4	$2M	Buy	+46,900	New	+$1.69M	0.01%	788

Axa's AMAG Position: Q4 2020 in Review

Axa sold out of AMAG Pharmaceuticals (AMAG) in Q4 2020, closing a stake of 188,200 shares — an estimated $1.77M sold.

Axa first reported a position in AMAG in Q4 2014 and held it in 15 quarters. The position peaked at $3.59M in Q2 2015. 1 fund tracked by Wall St. Rank holds AMAG as of Q4 2020.

Axa reported no remaining AMAG Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
Axa sold 188,200 AMAG Pharmaceuticals shares in Q4 2020, an estimated $1.77M.
Axa first reported a position in AMAG Pharmaceuticals in Q4 2014 and held it in 15 quarters.
Axa's AMAG Pharmaceuticals position peaked at $3.59M in Q2 2015.
1 fund tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2020.

Based on Axa's 13F filing for Q4 2020, filed 12 Feb 2021.